CompletedNot Applicable

Antibiotic Prophylaxis in Gynecologic Laparoscopy

Brazil114 participantsStarted 2013-09

Plain-language summary

Laparoscopy is a surgical procedure indicated for most gynecological pathologies and presents numerous advantages over laparotomy, among them lower rates of surgical site infection and less comorbidity feverish. Despite this, the use of antibiotic prophylaxis is widely accepted and performed by most gynecologists. However, there isn't literature evidence to support the routine use of antibiotics in the prophylaxis of wound infection on laparoscopic pelvic surgery .Therefore, this study will evaluate the need for the use of antibiotic prophylaxis in gynecological laparoscopies not including opening hollow viscera.

Who can participate

Age range18 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with gynecologic disease, undergoing gynecologic laparoscopy without opening hollow viscera. Exclusion Criteria: * body mass index over 30 Kg/m2 * smoking * diabetes type I or II with glycated hemoglobin exceeding 6.5% * patients who are at surgical risk classification of the American Society of Anesthesiologists(ASA) as ASA III or higher * refusal to participate * postoperative antibiotic therapy for another indication clinical complication

What they're measuring

Surgical site infection

Timeframe: 30 days

Trial details

NCT IDNCT01991834

SponsorUniversidade do Vale do Sapucai

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-03

View on ClinicalTrials.gov More Infection Secondary to Surgical Procedure trials